Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

The ORBITA trial and the future of percutaneous coronary intervention for stable angina

Konigstein, Maayana; Ben-Yehuda, Oria,b

doi: 10.1097/MCA.0000000000000624
Viewpoint

aCardiovascular Research Foundation

bDivision of Cardiology, Columbia University, New York, New York, USA

Correspondence to Ori Ben-Yehuda, MD, FACC, Clinical Trials Center, Cardiovascular Research Foundation, 1700 Broadway, Floor 9, New York, NY 10019, USA Tel: +1 646 582 6582; fax: +1 646 434 4711; e-mail: obenyehuda@crf.org

Received March 15, 2018

Accepted March 19, 2018

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.